Plant-based diets tied to long-term health benefits
May 15, 2024
The benefits include a better cardiometabolic risk profile as well as lower mortality.
AI-informed health app aids diabetes outcomes
May 15, 2024
The app gives tailored nutrition and health recommendations, which are linked to decreases in HbA1c and heart disease risk.
Long-term study of postmenopausal women does not support many preventive therapies
May 02, 2024
Hormone therapy was no aid for cardiovascular disease prevention, and calcium/vitamin D supplementation was no aid for universal fracture prevention.
Social determinants of health tied to atherosclerotic CVD risk
May 01, 2024
The authors say that social determinants could increase the prediction ability of risk tools, particularly for Black patients.
More medical lab tests will soon face federal scrutiny, FDA says
Apr 29, 2024
Laboratory tests used by millions of Americans are soon to be classified as medical devices, and as such be regulated by the US Food and Drug Administration, the agency announced Monday.
Good heart health may protect against cognitive decline in black women
Apr 24, 2024
The finding was seen for processing speed and cardiovascular health in Black women but not white women.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
How your residents can take control of their health with wearable devices
By
David Smith
Mar 16, 2023
The importance of preventive care increases significantly with age, especially when it comes to conditions as serious and common as heart disease. Far too many other older adults have succumbed to cardiovascular...
SGLT2 inhibitors may cut risk for heart failure hospitalization
Sep 28, 2021
SGLT2 inhibitors, compared with GLP-1 RAs, linked to lower risk for heart failure hospitalization in patients with T2DM, with or without cardiovasular disease.
